sbrothy
Gold Member
- 1,537
- 1,390
- TL;DR
- NIH-funded research identifies new mechanism of action for next-generation weight-loss drugs
Oral Small-Molecule GLP-1 Drugs Penetrate Deep Into the Brain to Suppress Cravings ((NIH)-funded study, post from May 6, 2026)..
This paper is somewhat over my paygrade but I found it interesting for a couple of reasons:
Also:
I know it's very abstract but the last comment there kinda gave me goosebumps. "Humanlike"?!
EDIT: With "over my paygrade" I meant the actual research paper
This paper is somewhat over my paygrade but I found it interesting for a couple of reasons:
A National Institutes of Health (NIH)-funded study has found that an emerging class of GLP-1 weight-loss drugs suppress eating for pleasure, or hedonic feeding, in mice by modulating a reward circuit deep within the brain. This newly charted pathway — separate from previously described mechanisms that broadly affect appetite — could be an avenue by which GLP-1s treat other dysfunctions in reward processing, such as substance use disorder.
Also:
To gain a better understanding, the authors modified the GLP-1 receptors of mice with gene-editing techniques, making them more humanlike.
I know it's very abstract but the last comment there kinda gave me goosebumps. "Humanlike"?!
EDIT: With "over my paygrade" I meant the actual research paper
Last edited:
